105772-65-4Relevant academic research and scientific papers
Synthesis of New Congeners of 1-methyl-3-aminoisoquinolines, Evaluation of Their Cytotoxic Activity, in Silico and in Vitro Study of Their Molecular Targets as PDE4B
Lapa, Gennady B.,Tsunoda, Toshiyuki,Shirasawa, Senji,Baryshnikova, Maria A.,Evseev, Gregory G.,Afanasyeva, Daria A.,Chigorina, Elena A.
, p. 575 - 582 (2016)
To examine the cytotoxic activity of congeners of 3-amino-isoquinoline, we performed the phenotypic screening using panel of 60 cell lines and found that (N-(6,7-dimethoxy-1-methyl-isoquinolin-3-yl)-4-{[(1-ethyl-4-methyl-1H-pyrazol-3-yl)methyl]amino}benzamide (4d)) exhibited the significant effect against different tumor cell lines while showing the high activity toward human colorectal cancer HCT-116 cells (IC50 = 18 μm) and human breast cancer T-47D cells (GI50 = 1.9 μm). Virtual screening indicated that these compounds target protein kinases and phosphodiesterases (PDE). However, wet screening among panel of protein kinases did not show any significant activity. By contrast, 50 μm of 4c and 4d inhibited the growth of HKe3-mtKRAS spheroids in the 3D floating (3DF) culture suggesting that 4c and 4d target PDE4B which is selectively upregulated by mtKRAS in 3DF culture.
Anticonvulsant agents
-
, (2008/06/13)
This invention provides certain benzamide derivatives of the formula: STR1 wherein Z is bond, --CH2 --, or CHCH3 ; A is --CH2 --, or CH2 CH2 --; and represents a single or double bond; and their pharm
